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Abstract
Aims: Lipid accumulation in non-adipose tissues leads to cell dysfunction and apoptosis, a phenomenon known as
lipotoxicity. Unsaturated fatty acids may offset the lipotoxicity associated with saturated fatty acids. Stearic acid
induced endoplasmic reticulum (ER) stress and caused apoptotic and necrotic cell death in the primary rat
hepatocytes.
Methods: Cell viability was investigated using MTT assay, and apoptosis was evaluated with Hoechst 33342
staining. Western blot analysis was used to examine the changes in the expression levels of glucose regulated
protein 78 (GRP78), glucose regulated protein 94 (GRP94), and C/EBP homologous protein (CHOP). Caspase-3
activity was evaluated using a Caspase-3 substrate kit.
Results: We have studied the ability of a-linolenic acid to prevent endoplasmic reticulum stress-mediated
apoptosis of rat hepatocytes elicited by stearic acid and thapsigargin. Incubation of primary rat hepatocytes for 16
h with stearic acid produced a significant increase in cell death. Stearic acid also increased levels of three indicators
of ER stress – GRP78, CHOP, and GRP94. a-Linolenic acid distinctly reduced cell death and levels of all three
indicators of ER stress brought about by stearic acid. Thapsigargin, which induces ER stress produced similar effects
to those obtained using stearic acid; its effects were partly reversed by a-linolenic acid.
Conclusion: These results suggest that a-linolenic acid prevents ER stress-mediated apoptosis of stearic acid
lipotoxicity on primary rat hepatocytes might become a target to develop new antiapoptotic compounds in
nonalcoholic fatty liver disease (NAFLD).
1. Introduction
The endoplasmic reticulum (ER) is a subcellular orga-
nelle where the vast majority of secreted and membrane
proteins are folded. Many kinds of cellular perturba-
tions, such as imbalances in calcium, loss of the luminal
oxidizing environment and/or nutrient homeostasis, can
lead to the accumulation of unfolded proteins and apop-
tosis[1,2]. The apoptosis is involved in the pathogenesis
of many diseases and conditions including ischemia-
reperfusion injury, diabetes and nonalcoholic fatty liver
disease (NAFLD) [3,4].
Hepatocyte death is a main feature of almost every
liver disease, with apoptosis characterized by biochem-
ical and morphological features being one of its modes.
Over the past ten years, thapsigargin (TG), has become
widely used as selective inhibitor of the ubiquitous
sarco-endoplasmic reticulum Ca2+-ATPases (SERCAs),
which pump Ca2+ from the cytosol into the lumen of
the endoplasmic reticulum (ER) in mammalian cells
[5-7] The latter mechanism of TG action has been
described in detail during the last twenty years [8]. It
has long been known that elevation of intracellular free
calcium ([Ca2+]i) has cytotoxic consequence in many
cells including hepatocytes [9]. ER function is mediated,
in part, by intraluminal Ca2+-binding proteins, which
include the glucose-regulated proteins GRP78 and
GRP94 [10,11].
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Several studies have linked ER dysfunction and activa-
tion of the unfolded protein response (UPR) to impair-
ments in glucose homeostasis and diabetes [12,13]. ER
stress and activation of the UPR in the liver have also
been observed in genetic and dietary murine models of
obesity, dietary models of NAFLD, and in humans with
NAFLD [13-15]. A large portion of the elevated hepatic
triglyceride stores in NAFLD appear to arise from re-
esterification of circulating free fatty acids [16]. Elevated
circulating free fatty acids are positively correlated with
liver disease severity in individuals with NAFLD [17].
Increased non-esterified fatty acids, in particular long
chain saturated fatty acids, induce ER stress and activate
the UPR in a number of cell types, including hepato-
cytes [15,18,19].
The metabolic signals that elicit ER stress are still
poorly defined. Recent studies imply that long-chain
saturated fatty acids, may induce ER stress in breast
cancer cells and liver cells [15,3,20]. Elevated lipids also
induce apoptosis in many cell types, thus ER stress and
an inability of the UPR to reestablish ER homeostasis
may be upstream components of lipotoxicity [20,21].
Therefore, impairments in ER homeostasis and the UPR
have been implicated in a number of disease states
including obesity, diabetes, hepatitis C, and NAFLD.
The present study had three aims: (1) To examine the
characteristics of fatty acid-mediated ER stress and
apoptosis in primary hepatocytes; (2) To determine
whether a-linolenic acid, an unsaturated fatty acid,
could provide protection against the cell death induced
by stearic acid; (3) once the beneficial actions of a-lino-
lenic acid were confirmed, this study inquiryed whether
these effects were mediated via modification of the ER
stress process with specific attention given to the role of
GRP78, GRP94 expression and induction of CHOP.
2. Materials and methods
2.1 Materials and cells
Rat hepatocytes were isolated from newborn (1-day-old)
Sprague-Dawley rats using the modified two-step col-
lagenase perfusion technique as previously described
[22]. Freshly prepared hepatocytes were seeded at a
density of 2 × 105 cells/well on 24-well multidishes pre-
coated with rat tail collagen type I solution in Williams
Medium E containing 5% of fetal calf serum, 100 nM
insulin, 2.5 μg/ml amphotericin B, 0.1 mg/ml gentami-
cin, 30 nM Na2SeO3, and 0.1 μM dexamethasone
(Sigma-Aldrich, St. Louis, MO). Calf serum and ampho-
tericin B were present for the first 24 h then omitted.
Cell culture materials and routine chemicals were
obtained from Sigma (Oakville, ON, Canada) or Fischer
Scientific (Nepean, ON, Canada). Primary antibodies
were obtained from Stressgen (Victoria, ON, Canada)
unless otherwise stated.
2.2. Incubation of primary hepatocytes
Cultured hepatocytes at 80-90% confluence, were incu-
bated with stearic acid (250 μmol/l) for up to 16 h.
Hepatocytes were also incubated with thapsigargin
(5 μmol/l). Further incubations were also performed
in which hepatocytes were incubated with stearic acid
(250 μmol/l) in the absence or presence of a-linolenic
(150 or 250 μmol/l) for up to 16 h.
2.3. Measurement of cell viability and death
Cell viability and death were assessed as described pre-
viously by measurement of the enzymatic conversion of
the yellow tetrazolium salt 3-(4, 5-dimethylthiazol-2-yl)-2,
5-diphenyltetrazolium bromide (MTT) into purple forma-
zan and the release of lactate dehydrogenase (LDH) from
lysed cells, respectively [23]. Primary rat hepatocytes were
stained with Hoechst 33342-propidium iodide (HPI) to
assess cell death by apoptosis and necrosis, respectively
[24]. Specifically, apoptotic cells were distinguished as
those with characteristic nuclear fragmentation and
intense staining of condensed chromatin. Propidium
iodide does not enter cells with intact plasma mem-
branes, however, after entering damaged apoptotic or
non-apoptotic cells it stains nuclear DNA pink. One
thousand, randomly distributed nuclei were counted per
sample and were scored as morphologically normal,
apoptotic and necrotic using an inverted fluorescence
microscope (Axiovert 25, Zeiss) set at excitation and
emission wavelengths of 365 and 397 nm, respectively.
2.4. Measurement of caspase-3 activation
Caspase-3 activity was evaluated using a DEVD-Nuc-
View™ 488 Caspase-3 substrate kit (Biotium Inc., Cam-
bridge, UK). In the presence of active caspase-3 enzyme,
the substrate dissociates from its bound fluorogenic
DNA-binding dye and the latter binds to DNA and
emits fluorescence. Caspase-3 was detected by micro-
scopic examination and also by adapting the kit for
microplate fluorescence reading. For this, cells were
incubated with 50 μL of 5 μmol/L DEVD-NucView™
488 Caspase-3 substrate for 30 min. Fluorescence was
measured in a microplate reader (Cary Eclipse, Varian
Inc.) set at wavelengths of 490 nm excitation and
520 nm emission.
2.5. Western blot analysis
Western blot analysis was performed as described in
detail previously [25]. Membranes were incubated with
antibodies against glucose-regulated protein 78 (GRP78;
Stressgen, Victoria BC, Canada), glucose-regulated pro-
tein 94 (GRP94; Stressgen, Victoria BC, Canada),
CCAAT/enhancer-binding protein homologous protein
(CHOP; Santa Cruz Biotechnology, Santa Cruz, CA), and
actin (Sigma). Proteins were detected with horseradish
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peroxidase-conjugated secondary antibodies (Amersham
Pharmacia Biotech, Piscataway, NJ) and an enhanced
chemiluminescence reagent (Pierce, Rockford, IL). Den-
sity was quantified using a UVP Bioimaging system
(Upland, CA).
2.6. Statistical analysis
Results are expressed as mean ± standard error of the
mean (S.E.M.) for n independent observations as indi-
cated. Statistical differences between mean values of
groups have been determined using one way analysis of
variance (ANOVA) followed by a Dunnett’s post-signifi-
cance test for comparison of multiple means using the
SPSS version 11.5. The level of significance was set at P
< 0.05.
3 Results
3.1. Stearic acid causes significant cellular death of
hepatocytes - protection by a-linolenic acid
Incubation of subconfluent cultures of the hepatocytes
with 250 μmol/l stearic acid for 16 h produced a signifi-
cant loss of cell viability as demonstrated by decreased
reduction of MTT and increased LDH release (Figure
1A). The mode of cell death observed at this concentra-
tion of stearic acid was a combination of apoptosis and
necrosis as determined using a combination of HPI
staining (Figure 1B). However, co-incubation of primary
rat hepatocytes with 250 μmol/l stearic acid and 150 or
250 μmol/l a-linolenic acid restored cell viability to
levels observed in untreated cells (Figure 1A).
Stearic-mediated apoptosis of primary rat hepatocytes
coincided with a significant increase in caspase-3 activa-
tion (Figure 2B). Thapsigargin as well as stearic acid
increased fluorescence in the caspase 3 assay confirming
activation of apoptosis pathways (Figure 2B).
3.2. a-Linolenic acid reduces ER stress mediated by
stearic acid
Stearic acid produced a significant increase in the
expression of markers of ER stress. After 16 h incuba-
tion with stearic acid, increased levels of GRP78, GRP94
and CHOP were also detected (Figure 2).
In the presence of a-linolenic acid, ER stress mediated
by stearic acid was significantly reduced. Co-incubation
of hepatocytes with 250 μmol/l stearic acid and 150 or
250 μmol/l a-linolenic acid produced a significant
reduction in levels of GRP78, GRP94 and CHOP after
16 h (Figure 2).
3.3. Effects of a-linolenic acid on primary rat hepatocytes
death mediated by thapsigargin
Incubation of primary rat hepatocytes with 5 μmol/l
thapsigargin for 16 h causes significant increases in cell
death (Figure 3A). a-Linolenic acid at concentrations of
250 μmol/l, was able to increase cell viability signifi-
cantly (Figure 3A) – an effect which was reflected by a
significant reduction in the caspase-3 of apoptotic cells
(Figure 3B).
3.4. Effects of a-linolenic acid on ER stress induced by
thapsigargin
Incubation of primary rat hepatocytes with 5 μmol/l
thapsigargin for 16 h produced a significant increase in
levels of CHOP (Figure 4A, C). a-Linolenic acid, at con-
centrations of 250 μmol/l, was able to reduce the
increase in CHOP levels produced by 5 μmol/l thapsi-
gargin (Figure 4A, C). But, neither concentration was
able to reduce GRP78 expression mediated by thapsigar-
gin (Figure 4A, B).
4. Discussion
The delivery and accumulation of lipids in non-adipose
tissues leads to cellular dysfunction and death. This phe-
nomenon, termed lipotoxicity, has been implicated in
the pathogenesis of diabetes, cardiac failure and NAFLD
[13,26,27]. Disruption of ER homeostasis and activation
Figure 1 Effects of SA on primary rat hepatocytes . (A)
Treatment with stearic acid (SA) for 16 h produced significant and
concentration-dependent effects on MTT reduction and LDH
release. Data represent mean ± S.E.M., n = 5,*P < 0.05 vs. control (0
μmol/l stearic acid), **P < 0.05 vs. stearic acid-only cells. (B)
Treatment of primary rat hepatocytes with 250 μmol/L SA produced
a significant increase in activity of caspase-3. For comparison, the
effects of thapsigargin(Thap; 5 μmol/l)are also shown. Data
represent mean ± S.E.M., n = 5,*P < 0.05 vs. control (0 μmol/l stearic
acid), **P < 0.05 vs. stearic acid-only cells.
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of the UPR has been observed in murine models of obe-
sity, cardiac dysfunction and NAFLD [13,15,28].
Increased free fatty acids, in particular long chain
saturated fatty acids, induce ER stress, activate the UPR
and promote cell death in a number of cell types,
including hepatocytes [29,26,30-32]. Thus, impairments
in ER function appear to contribute to the pathogenesis
of several diseases and to cellular impairments asso-
ciated with lipotoxicity. The present study was underta-
ken to begin to examine the mechanisms that link
saturated fatty acids to ER stress, In this study, we
report that (1) stearic acid causes significant cell death
in primary rat hepatocytes. (2) stearic acid causes a sig-
nificant degree of ER stress in primary rat hepatocytes.
(3) a-linolenic acid protects primary rat hepatocytes
against stearic acid lipotoxicity by reducing ER stress
and apoptosis. The effects of stearic acid were similar to
those observed using generated by saturated dietary free
fatty acids. a-Linolenic acid was also able to reduce
cellular dysfunction and apoptosis caused by thapsigar-
gin – one recognised inducer of ER stress. Thapsigargin
causes apoptosis in many other cells such as neuronal
cells, pancreatic beta-cells and cardiomyocytes [33-35].
The mechanism underlying the necrotic cell death
Figure 2 a-Linolenic acid protects primary rat hepatocytes
against ER stress induced by stearic acid. (A)Western blot and (B)
densitometric analysis demonstrating the reduction of stearic acid
(SA)-induced GRP78 expression by 150 or 250 μmol/l a-linolenic
acid (ALA) after 16 h. (A)Western blot and (C) densitometric analysis
of GRP94 expression after 16 h incubation of cells with 250 μmol/l
stearic acid(SA) in presence of 150 or 250 μmol/l a-linolenic acid
(ALA). (A)Western blot and (D) densitometric analysis demonstrating
the reduction of stearic acid (SA)-induced CHOP expression by 150
or 250 μmol/l a-linolenic acid (ALA) after 16 h. Data represent mean
± S.E.M., n = 5, *P < 0.05 vs. LG, low glucose control (0 μmol/l
stearic acid), **P < 0.05 vs. stearic acid-only cells.
Figure 3 a-Linolenic acid protects against dysfunction and
apoptosis of primary rat hepatocytes induced by thapsigargin.
Relative cell death(A) and relative caspase-3 expression(B) treated
with 5 μmol/l thapsigargin (Thap) for 16 h in presence of 150 or
250 μmol/l a-linolenic acid (ALA). Data represent mean ± S.E.M., n =
5, *P < 0.05 vs. LG, low glucose control set to 1 (0 μmol/l stearic
acid), **P < 0.05 vs. thapsigargin-only cells.
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produced by thapsigargin is still not clear. It is possible
that by protecting cells against thapsigargin-induced
apoptosis, a-linolenic acid alleviated primary rat hepato-
cytes damaged.
Recent evidence has linked saturated fatty acid-
induced apoptosis to the activation of JNK, pro-apopto-
tic Bcl-2 proteins, Bim and Bax, and the mitochondrial
apoptotic pathway in liver cells [36]. Long-chain satu-
rated fatty acids also induce the ER-associated pro-apop-
totic factor, CHOP, which suggests that disruption of ER
homeostasis may also be directly linked to apoptosis. In
several cell types, including liver, co-supplementation of
oleate and palmitate reduces palmitate-mediated ER
stress and apoptosis [30,37,38]. Toward this end, the
ability of long chain saturated fatty acids to activate the
ER-associated caspase-3 was examined.
In this study, we have demonstrated for the first time
that ER stress produced by stearic acid in primary rat
hepatocytes can be significantly reduced by a-linolenic
acid, an unsaturated fatty acid. We also report that the
protection afforded by an unsaturated fatty acid involves
a reduction of ER stress. The mechanism involves a
reduction in the raised levels of caspase-3 and CHOP
associated with stearic acid, however the results of our
investigation appears to rule out a protective mechanism
mediated by GRP78 as a-linolenic acid did not signifi-
cantly affect levels of this chaperone molecule whereas
levels of CHOP were significantly reduced.
To summarize, the results presented here suggest that
unsaturated fatty acids such as a-linolenic acid may be
able to offer protection of hepatocytes against the lipo-
toxicity of saturated fatty acids such as dietary stearic
acid and nutrient overload associated with obesity and
NAFLD.
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